Small left ventricle in patients with heart failure with preserved ejection fraction is associated with higher mortality

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Yusuke Nakagawa

Kawanishi City Medical Center, Kawanishi (Japan)

5 More presentations in this session

Presentation thumbnail

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients

Doctor M. Dagan (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing

Doctor S. Brown (London, GB)

Abstract Slides Video

Presentation thumbnail

Gender-specific outcomes and treatment responses in elderly HFpEF patients: a comprehensive single-center retrospective study

Doctor K. Shi (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction

Doctor J. Kassab (Dallas, US)

Abstract Slides Video

Presentation thumbnail

Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction

Doctor S. Ratwatte (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

HFpEF issues

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Small heart size and premature death in 366,484 individuals with normal ejection fraction

Congress Presentation

Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction

Congress Presentation

Long-term clinical course of heart failure across left ventricular ejection fraction phenotypes

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources